In vitro produced human antibodies in the treatment of superficial bladder cancer.
作者信息
Corrado F, Pizza G, Casanova S, De Vinci C, Fini M, Severini G, Menniti D, Corrado G
机构信息
First Division of Urology and Experimental Urology Service, M. Malpighi Hospital, Bologna, Italy.
出版信息
J Exp Pathol. 1987 Summer;3(4):347-58.
PMID:3454800
Abstract
摘要
相似文献
1
In vitro produced human antibodies in the treatment of superficial bladder cancer.体外产生的人抗体在浅表性膀胱癌治疗中的应用
J Exp Pathol. 1987 Summer;3(4):347-58.
2
Antibody drug carrier for immunotherapy of superficial bladder cancer: ultrastructural studies.用于浅表性膀胱癌免疫治疗的抗体药物载体：超微结构研究
Cancer Res. 1992 Jun 1;52(11):3131-7.
3
Interleukin-2 in the treatment of infiltrating bladder cancer.白细胞介素-2治疗浸润性膀胱癌
J Exp Pathol. 1987 Summer;3(4):525-31.
4
5
In vitro production of human antibodies against bladder cancer: characterization and diagnostic implications.人抗膀胱癌抗体的体外产生：表征及诊断意义
J Exp Pathol. 1987 Summer;3(4):335-46.
6
High grade superficial (G3t1) transitional cell carcinoma of the bladder treated with intravesical Bacillus Calmette-Guerin (BCG).采用膀胱内灌注卡介苗（BCG）治疗的高级别浅表性（G3t1）膀胱移行细胞癌。
J Exp Clin Cancer Res. 2003 Dec;22(4 Suppl):223-7.
7
Therapy of superficial bladder cancer.
Semin Oncol. 1996 Oct;23(5):598-604.
8
High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.高危浅表性膀胱癌：膀胱内灌注治疗膀胱T1 G3移行细胞癌
Semin Urol Oncol. 1997 Aug;15(3):147-53.
9
10
[Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].[尿BTA-TRAK在浅表性移行细胞膀胱癌随访中的应用]
Arch Esp Urol. 2002 Jan-Feb;55(1):41-9.
Zotero 插件